InvestorsHub Logo
Followers 13
Posts 1557
Boards Moderated 0
Alias Born 06/14/2018

Re: None

Wednesday, 02/07/2024 1:54:42 PM

Wednesday, February 07, 2024 1:54:42 PM

Post# of 34700
New T cell therapy for Lymphoma ... clinical trials still a few years away.
https://www.msn.com/en-us/health/other/new-technique-could-make-human-t-cells-100-times-more-potent-at-killing-cancer-cells/ar-BB1hVKbW?ocid=msedgdhp&pc=U531&cvid=7a02c55157864e2ba3eef48328824d64&ei=17

"a gene fusion, CARD11–PIK3R3, found in a CD4 cutaneous T cell lymphoma, that augments CARD11–BCL10–MALT1 complex signalling and anti-tumour efficacy of therapeutic T cells in several immunotherapy-refractory models in an antigen-dependent manner."
https://www.nature.com/articles/s41586-024-07018-7
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent MRKR News